We ultimately chose the licensing agreement that l

Quote:

---

We ultimately chose the licensing agreement that left the company with the freedom to complete development and then sell our in-development GenChoice TBG and upcoming CGM TBG products.

---

https://www.otcmarkets.com/stock/DECN/news/DE...?id=235981



Continuous Blood Glucose Monitoring Market Upcoming Demand & Growth Analysis Up to 2025

https://amazingherald.com/continuous-blood-gl...p-to-2025/

Companies Mentioned: Dexcom, Inc., Abbott, Bayer AG, F. Hoffmann-La Roche, Arkray Inc., Cellnovo, Echo Therapeutics Inc., Nemaura, Tandem Diabetes Care, Inc., and PharmaTech Solutions, Inc. among Others



Blood Glucose Sensor Patch Market is Growing at a Highest CAGR by 2026


https://ustrademedia.com/global-blood-glucose...ch-market/


Influencing players of this market are: Abbott, Apple Inc., Ascensia Diabetes Care Holdings AG, Cellnovo, Debiotech S.A., Glooko, Insulet Corporation, Johnson & Johnson Services, myDario.com, Medella Health Inc., Medtronic, Nemaura, Novo Nordisk, Onduo LLC, Pharma Tech Solutions, F. Hoffmann- La Roche, Sanofi, Tandem Diabetes Care


GoDECN!